In this study, we established an integrated multiomics MR framework that combines DNA methylation, immune cell, and metabolite data to investigate the causal role and potential mechanisms of ITGB7 in CHD, providing new molecular evidence and potential targets for the precision prevention and treatment of cardiovascular diseases. Here, ITGB7 is linked to coronary artery disorder.